Log in

NASDAQ:ANABAnaptysBio Insider Trades

$19.44
+0.77 (+4.12 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$18.92
Now: $19.44
$20.24
50-Day Range
$15.28
MA: $17.86
$19.92
52-Week Range
$10.00
Now: $19.44
$77.29
Volume386,493 shs
Average Volume357,496 shs
Market Capitalization$530.32 million
P/E RatioN/A
Dividend YieldN/A
Beta0.92

Insider Trades

AnaptysBio (NASDAQ:ANAB) Insider Buying and Selling Activity

Insider Ownership Percentage: 14.00%

Insider Buying and Selling by Quarter


AnaptysBio (NASDAQ ANAB) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/10/2019Hamza SuriaCEOSell22,428$73.76$1,654,289.2831,524  
6/4/2019Marco LondeiInsiderSell10,060$73.06$734,983.6032,437  
1/15/2019Marco LondeiInsiderSell19,075$69.88$1,332,961.0022,377  
1/14/2019Hamza SuriaCEOSell40,000$70.79$2,831,600.0070,064  
12/17/2018Marco LondeiInsiderSell30,048$66.76$2,006,004.48152,925  
12/14/2018Hamza SuriaCEOSell41,728$69.36$2,894,254.0871,792  
12/12/2018Hamza SuriaCEOSell65,585$71.47$4,687,359.9565,649  
12/10/2018Hamza SuriaCEOSell30,587$71.19$2,177,488.5365,649  
12/3/2018Dominic PiscitelliCFOSell37,000$72.14$2,669,180.0037,000  
4/16/2018Nicholas LydonDirectorSell33,000$86.88$2,867,040.00301,506  
8/21/2017Holdings A/S NovoMajor ShareholderSell356,300$21.10$7,517,930.001,936,604  
8/15/2017Holdings A/S NovoMajor ShareholderSell178,600$21.16$3,779,176.002,436,332  
8/7/2017Holdings A/S NovoMajor ShareholderSell491,294$21.12$10,376,129.282,952,527  
8/3/2017Holdings A/S NovoMajor ShareholderSell70,706$23.31$1,648,156.863,009,949  
7/26/2017Ventures Vii L P AvalonMajor ShareholderSell37,040$24.35$901,924.00  
1/31/2017Healthcare Vii L.P. FrazierMajor ShareholderBuy400,000$15.00$6,000,000.00  
1/31/2017Nicholas LydonDirectorBuy16,666$15.00$249,990.00270,957  
(Data available from 1/1/2013 forward)
This page was last updated on 6/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.